
antoniofagundesjr
@fagundes_anton
Intesivist/Cardiologist, #Zentensivist, father and science lover. ICU Chair, DFStar Hospital Researcher at IDOR Research Institute
ID: 960340437289656320
05-02-2018 02:32:57
778 Tweet
234 Followers
1,1K Following


Primary results from Bridge-TIMI 73a Late Breaking Clinical Trial presented by Brian Bergmark at #ACC24 show that #olezarsen reduces #triglyceride levels by ~50% without major safety concerns. Now published in NEJM. Nicholas Marston





#ACC24 #SimPub in Circulation by Sid M. Patel & #SMARTc investigators Massive effort evaluating 78,607 patients across 11 late-phase trials in diabetes, CKD, & HF providing definitive evidence of the effects of #SGLT2i on #MACE ahajournals.org/doi/10.1161/CI…




#AHA24: How does the benefit of microaxial flow pumps in cardiogenic shock vary by age? In a new analysis of the DanGer Shock trial, Dr. Jacob Møller & team at Research Unit of Cardiology, OUH find that these devices may not benefit older patients (>77 y/o) bit.ly/3Z56S3L #JACC #cvGeri




Drs. Eugene Braunwald and Marc Sabatine giving Cardiovascular Grand Rounds Brigham and Women's Hospital on the 40th anniversary of the TIMI Study Group. timi.org/timis-40th-ann…





Hot off the press! Evolution of Critical Care Cardiology JACC Journals Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Bram Geller, MD Abdulla A. Damluji, MD, PhD Christopher Barnett MD, MPH, FACC Erin Bohula venu menon Robert Roswell Saraschandra Vallabhajosyula, MD MSc Dr Amanda Vest #CynthiaArslanian #DavidMorrow Sarah Perman MD MSCE Society Of Critical Care Cardiology jacc.org/doi/10.1016/j.…



